Anthony G Creber
Suite 2600, 160 Elgin Street
K1P 1C3
Biography: Patents
Anthony Creber is a partner and leading patent litigation practitioner in Gowlings' Ottawa office. His practice has evolved to include trademark litigation, regulatory issues and advising on strategic IP life cycle matters. Anthony's primary focus has been in chemical and pharmaceutical patent litigation.He has appeared extensively in the Federal Court (both Trial and Appeal and including the Supreme Court of Canada) on patent matters, including questions of patentability of life forms, patent licensing and the infringement of biotech patents, including the recent SCC decision in Schmeiser v Monsanto. Generally Anthony appears for patentees and represents many major pharmaceutical companies, including Eli Lilly, GSK, BMS, Schering-Plough, Novartis, Hoffmann-La Roche, Janssen-Ortho, and Sanofi.
As the lead partner in the Apotex v Sanofi-Synthelabo Canada case, Anthony won the coveted "Patent Case of the Year 2009" award given by Managing Intellectual Property. The Financial Times (Europe) recently featured Anthony's patent victory for the same case wherein the Canadian Federal Court granted Sanofi's request to block a challenge by Apotex, Canada's leading generic drugmaker, against its Plavix patent.
He is a registered patent and trademark agent and is permitted to practice before the US Patent and Trademark Office as a patent agent.
Anthony has been listed as a leading lawyer in several legal industry publications, including The International Who's Who of Business Lawyers, Canadian Legal Lexpert Directory, IAM Patent Litigation 250: The World's Leading Patent Litigators, Chambers Global, Who's Who Legal: Canada, Expert Guides' Guide to the World's Leading Patent Law Practitioners, PLC Which Lawyer? Yearbook, Lexpert/ALM Guide to the Leading 500 Lawyers in Canada, Lexpert Guide to the Leading US/Canada Cross-Border Litigation Lawyers in Canada and Best Lawyers in Canada.
Anthony is a member of the Canadian Bar Association, the Intellectual Property Institute of Canada and the International Bar Association.
This biography is an extract from Who's Who Legal: Canada which can be purchased from our Bookstore.
Biography: Life Sciences
Anthony Creber is a partner and leading patent litigation practitioner in Gowlings' Ottawa office. His practice has evolved to include trademark litigation, regulatory issues and advising on strategic IP life cycle matters. Tony's primary focus has been in chemical and pharmaceutical patent litigation.He has appeared extensively in the federal court (both trial and appeal and including the Supreme Court of Canada) on patent matters, including questions of patentability of life forms, patent licensing and the infringement of biotech patents, including the recent SCC decision in Schmeiser v Monsanto. Generally, Tony appears for patentees and represents many major pharmaceutical companies, including Eli Lilly, GSK, BMS, Schering-Plough, Novartis, Hoffmann-La Roche, Janssen-Ortho and Sanofi.
As the lead partner in the Apotex v Sanofi-Synthelabo Canada case, Tony won the coveted "Patent Case of the Year 2009" award given by Managing Intellectual Property. The Financial Times (Europe) recently featured Tony's patent victory for the same case wherein the Canadian Federal Court granted Sanofi's request to block a challenge by Apotex, Canada's leading generic drugmaker, against its Plavix patent.
Tony is a registered patent and trademark agent and is permitted to practice before the US patent and trademark office as a patent agent.
This biography is an extract from The International Who's Who of Life Sciences Lawyers which can be purchased from our Bookstore.
It is not possible to buy entry into any Who's Who Legal publication
Nominees have been selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met independent international research criteria are listed.